CYPLEVEQ

Dead / Abandoned — Abandoned — after publication (as of 22 Sept 2026)

What this means for you

This application is over — abandoned 21 Sept 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
99696409
Mark type
Word mark
Filed
11 Mar 2026
Published for opposition
18 Aug 2026
Abandoned
21 Sept 2026
Attorney of record
Marilyn F. Kelly

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes

Owner

Board proceedings on this mark

Prosecution history

  • 22 Sept 2026 — ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
  • 22 Sept 2026 — ABANDONMENT - AFTER PUBLICATION
  • 21 Sept 2026 — TEAS EXPRESS ABANDONMENT RECEIVED
  • 16 Sept 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
  • 18 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 18 Aug 2026 — PUBLISHED FOR OPPOSITION
  • 12 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 17 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 17 Jul 2026 — ASSIGNED TO EXAMINER
  • 16 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 11 Mar 2026 — APPLICATION FILING RECEIPT MAILED
  • 11 Mar 2026 — NEW APPLICATION ENTERED

View this trademark record on Rightsy